AI in Healthcare

India Has Its First AI-Powered Mammography Machine — Fujifilm's AMULET SOPHINITY Is Now Installed at NM Medical Mumbai

By Mustafa Shariff, Editor in Chief · June 16,2026 · 2 min read

Mustafa Shariff, Editor in Chief — India Has Its First AI-Powered Mammography Machine — Fujifilm's AMULET SOPHINITY Is Now Installed at NM Medical Mumbai

Summary

  • Fujifilm AMULET SOPHINITY: India's First AI-Powered Mammography System Installed at NM Medical Mumbai
  • FUJIFILM India has installed its first AI-powered digital mammography system, AMULET SOPHINITY, at NM Medical in Mumbai. Here is what AI-assisted mammography means for breast cancer detection in India.

"Breast cancer remains the leading cancer among women in India with over 2.32 lakh cases projected in 2025. AI-assisted mammography represents a critical step in improving diagnostic accuracy, reducing false positives, and enabling earlier detection at scale."

FUJIFILM India, a leader in advanced diagnostic imaging solutions, has announced the installation of its latest AI-Powered Digital Mammography System, AMULET SOPHINITY, at NM Medical in Khar, Mumbai — the first installation of this system anywhere in India. The announcement was made at an installation event at NM Medical, reinforcing FUJIFILM India's commitment to advancing women's healthcare through precision imaging and AI-assisted diagnostics.

Breast cancer is the leading cancer among women in India. The Indian Council of Medical Research's National Cancer Registry Programme projects over 2.32 lakh new breast cancer cases in Indian women in 2025, making it the single most significant oncological threat to women's health in the country. Early detection dramatically improves outcomes: breast cancer detected at Stage 1 has five-year survival rates above 90%, compared to under 30% for Stage 4 diagnosis. The gap between what early detection can achieve and what India currently delivers — given limited access to quality mammography outside major cities and inconsistent reporting standards — represents one of the most significant preventable mortality gaps in Indian women's healthcare.

What AMULET SOPHINITY Provides

The AMULET SOPHINITY system combines three technological capabilities that distinguish it from conventional digital mammography. Low-dose imaging technology reduces the radiation exposure per examination compared to earlier-generation mammography systems — an important consideration for mammography programmes that involve repeated screening examinations over a patient's lifetime, and for patients who have anxiety about radiation exposure as a barrier to screening participation.

Enhanced visualisation provides improved image quality through advanced detector technology and image processing algorithms, enabling clearer delineation of suspicious tissue densities — particularly in women with dense breast tissue, where conventional mammography has lower sensitivity for detecting early-stage tumours. Dense breast tissue is more common in younger women and in South Asian populations, making enhanced visualisation specifically valuable for the Indian patient demographic.

AI-assisted analysis is the defining capability. The system's AI algorithms analyse mammography images to identify and flag areas of concern — calcifications, masses, and architectural distortions — providing radiologists with a second reader that consistently applies learned pattern recognition across every examination. AI-assisted mammography has been shown in multiple clinical studies to reduce false negative rates (missed cancers) and reduce reader variability between different radiologists, improving the consistency of breast cancer screening across a diagnostic network.

The NM Medical Partnership

NM Medical in Khar, Mumbai, is a leading diagnostic healthcare provider with established expertise in advanced imaging and diagnostic services across multiple specialties. NM Medical's choice to install India's first AMULET SOPHINITY reflects both the institution's commitment to clinical innovation and its understanding that AI-assisted mammography represents the next standard for women's preventive imaging — moving from a technology that is available at a few specialist centres to one that can be deployed in diagnostic facilities that serve a broad urban population.

BHC Perspective

At Bengaluru Health Community, the first AI mammography installation in India is a diagnostics story with profound women's health implications. Over 2.32 lakh new breast cancer diagnoses annually and a healthcare system that detects most cases at advanced stages represent a preventable mortality burden that AI-assisted screening is designed to reduce. For BHC founders in cancer diagnostics, AI radiology, or women's health technology — this installation marks the beginning of AI mammography's commercial deployment in India.

Frequently Asked Questions

Q: What is Fujifilm's AMULET SOPHINITY?
A: An AI-powered digital mammography system combining low-dose imaging, enhanced visualisation, and AI algorithms that flag suspicious lesions and support radiologists in early breast cancer detection. First installed in India at NM Medical, Khar, Mumbai on June 9, 2026.

Q: Why does AI mammography matter for India?
A: India projects over 2.32 lakh new breast cancer cases annually, with most detected at advanced stages. AI-assisted mammography reduces false negatives, improves reader consistency, and enables earlier detection — particularly for women with dense breast tissue, more common in younger and South Asian populations.

Q: What does AI add to conventional mammography?
A: A consistent second-reader that applies AI pattern recognition across every examination, flagging calcifications, masses, and architectural distortions. Multiple studies demonstrate reduced missed cancers and lower variability between radiologists compared to conventional reading alone.